GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,441,749 | -6.8% | 451,999 | +11.8% | 0.01% | 0.0% |
Q2 2023 | $24,067,082 | +18.9% | 404,217 | +13.1% | 0.01% | +14.3% |
Q1 2023 | $20,246,027 | -11.7% | 357,451 | +15.7% | 0.01% | -22.2% |
Q4 2022 | $22,940,668 | +15.9% | 308,882 | -7.1% | 0.01% | +12.5% |
Q3 2022 | $19,799,000 | +0.0% | 332,352 | -5.8% | 0.01% | +14.3% |
Q2 2022 | $19,798,000 | -23.2% | 352,647 | +0.9% | 0.01% | -12.5% |
Q1 2022 | $25,790,000 | -13.8% | 349,558 | -15.6% | 0.01% | -11.1% |
Q4 2021 | $29,910,000 | +11.3% | 414,263 | +18.2% | 0.01% | 0.0% |
Q3 2021 | $26,864,000 | -2.5% | 350,612 | -1.3% | 0.01% | 0.0% |
Q2 2021 | $27,548,000 | +13.7% | 355,325 | -9.6% | 0.01% | 0.0% |
Q1 2021 | $24,233,000 | -10.7% | 392,938 | -5.6% | 0.01% | -18.2% |
Q4 2020 | $27,141,000 | +46.4% | 416,133 | +11.1% | 0.01% | +37.5% |
Q3 2020 | $18,544,000 | +1.1% | 374,461 | -2.6% | 0.01% | -11.1% |
Q2 2020 | $18,337,000 | +24.7% | 384,341 | +36.5% | 0.01% | 0.0% |
Q1 2020 | $14,705,000 | +1.4% | 281,603 | +13.3% | 0.01% | +28.6% |
Q4 2019 | $14,505,000 | +9.8% | 248,581 | -5.5% | 0.01% | 0.0% |
Q3 2019 | $13,205,000 | +1.2% | 263,053 | -14.7% | 0.01% | 0.0% |
Q2 2019 | $13,053,000 | -4.6% | 308,564 | +10.6% | 0.01% | -12.5% |
Q1 2019 | $13,686,000 | +9.4% | 279,069 | -3.4% | 0.01% | -20.0% |
Q4 2018 | $12,507,000 | +210.3% | 288,987 | +307.0% | 0.01% | +233.3% |
Q3 2018 | $4,030,000 | +12.6% | 71,011 | +0.1% | 0.00% | 0.0% |
Q2 2018 | $3,580,000 | +0.5% | 70,949 | -0.8% | 0.00% | 0.0% |
Q1 2018 | $3,563,000 | +34.7% | 71,530 | +11.2% | 0.00% | +50.0% |
Q4 2017 | $2,646,000 | +45.9% | 64,315 | +5.4% | 0.00% | +100.0% |
Q3 2017 | $1,813,000 | -1.9% | 61,027 | +9.6% | 0.00% | 0.0% |
Q2 2017 | $1,848,000 | +34.3% | 55,704 | +19.9% | 0.00% | 0.0% |
Q1 2017 | $1,376,000 | +41.1% | 46,475 | +18.3% | 0.00% | 0.0% |
Q4 2016 | $975,000 | +197.3% | 39,282 | +169.1% | 0.00% | – |
Q3 2016 | $328,000 | -8.1% | 14,595 | -2.8% | 0.00% | – |
Q2 2016 | $357,000 | +0.3% | 15,009 | 0.0% | 0.00% | – |
Q1 2016 | $356,000 | -5.8% | 15,009 | +11.3% | 0.00% | – |
Q4 2015 | $378,000 | +42.6% | 13,490 | +6.7% | 0.00% | – |
Q3 2015 | $265,000 | -18.5% | 12,640 | 0.0% | 0.00% | – |
Q2 2015 | $325,000 | +13.6% | 12,640 | +10.8% | 0.00% | – |
Q1 2015 | $286,000 | +27.1% | 11,409 | +21.7% | 0.00% | – |
Q4 2014 | $225,000 | +19.7% | 9,371 | -2.8% | 0.00% | – |
Q3 2014 | $188,000 | – | 9,637 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |